I B Bayer-Garner

Summary

Affiliation: Marshfield Clinic
Country: USA

Publications

  1. ncbi Immunolabeling pattern of syndecan-1 expression may distinguish pagetoid Bowen's disease, extramammary Paget's disease, and pagetoid malignant melanoma in situ
    Ilene B Bayer-Garner
    Marshfield Clinic, Marshfield, WI, USA
    J Cutan Pathol 31:169-73. 2004
  2. ncbi The immunopathology of regression in benign lichenoid keratosis, keratoacanthoma and halo nevus
    Ilene B Bayer-Garner
    Department of Pathology, Marshfield Clinic, Marshfield, Wisconsin 54449, USA
    Clin Med Res 2:89-97. 2004
  3. ncbi Monkeypox virus: histologic, immunohistochemical and electron-microscopic findings
    I B Bayer-Garner
    Marshfield Clinic, Marshfield, WI 54449, USA
    J Cutan Pathol 32:28-34. 2005
  4. ncbi Routine syndecan-1 immunohistochemistry aids in the diagnosis of chronic endometritis
    Ilene B Bayer-Garner
    Department of Pathology, Marshfield Clinic, Marshfield, Wis 54449, USA
    Arch Pathol Lab Med 128:1000-3. 2004
  5. ncbi Carcinoma with thymus-like differentiation arising in the dermis of the head and neck
    I B Bayer-Garner
    Marshfield Clinic, Marshfield, WI 54449, USA
    J Cutan Pathol 31:625-9. 2004
  6. ncbi The expression of syndecan-1 is preferentially reduced compared with that of E-cadherin in acantholytic squamous cell carcinoma
    I B Bayer-Garner
    Department of Pathology, University of Arkansas for Medical Sciences, Little Rock 72205, USA
    J Cutan Pathol 28:83-9. 2001
  7. ncbi Plasma cells in chronic endometritis are easily identified when stained with syndecan-1
    I B Bayer-Garner
    Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, USA
    Mod Pathol 14:877-9. 2001
  8. ncbi Expression of syndecan-1 is a sensitive marker for cutaneous plasmacytoma
    Ilene B Bayer-Garner
    Department of Pathology, University of Arkansas for Medical Sciences, 4301 West Markham Street, Little Rock, AR 72205, USA
    J Cutan Pathol 30:18-22. 2003
  9. ncbi Syndecan-1 (CD138) immunoreactivity in bone marrow biopsies of multiple myeloma: shed syndecan-1 accumulates in fibrotic regions
    I B Bayer-Garner
    Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, USA
    Mod Pathol 14:1052-8. 2001
  10. ncbi Detection of clonality with kappa and lambda immunohistochemical analysis in cutaneous plasmacytomas
    Ilene B Bayer-Garner
    Department of Pathology, Marshfield Clinic, Marshfield, Wis 54449, USA
    Arch Pathol Lab Med 128:645-8. 2004

Collaborators

Detail Information

Publications19

  1. ncbi Immunolabeling pattern of syndecan-1 expression may distinguish pagetoid Bowen's disease, extramammary Paget's disease, and pagetoid malignant melanoma in situ
    Ilene B Bayer-Garner
    Marshfield Clinic, Marshfield, WI, USA
    J Cutan Pathol 31:169-73. 2004
    ..The patterns of syndecan-1 immunoreactivity in these lesions may be a useful adjunct in the differentiation of PBD, EPD, and MIS...
  2. ncbi The immunopathology of regression in benign lichenoid keratosis, keratoacanthoma and halo nevus
    Ilene B Bayer-Garner
    Department of Pathology, Marshfield Clinic, Marshfield, Wisconsin 54449, USA
    Clin Med Res 2:89-97. 2004
    ..Regression is a phenomenon present in a variety of cutaneous lesions. It is likely that similar immunologic mechanisms explain the phenomenon of spontaneous regression occurring in the various lesions...
  3. ncbi Monkeypox virus: histologic, immunohistochemical and electron-microscopic findings
    I B Bayer-Garner
    Marshfield Clinic, Marshfield, WI 54449, USA
    J Cutan Pathol 32:28-34. 2005
    ..Initially, it presents with skin eruptions and fevers with diaphoresis and rigors. Clinically, the skin lesions progress from papules to vesiculopustules to resolving eschars...
  4. ncbi Routine syndecan-1 immunohistochemistry aids in the diagnosis of chronic endometritis
    Ilene B Bayer-Garner
    Department of Pathology, Marshfield Clinic, Marshfield, Wis 54449, USA
    Arch Pathol Lab Med 128:1000-3. 2004
    ..Syndecan-1 is a proteoglycan that is found on the cell surface of plasma cells and keratinocytes. Immunohistochemistry stains for this antibody may facilitate diagnosis of chronic endometritis...
  5. ncbi Carcinoma with thymus-like differentiation arising in the dermis of the head and neck
    I B Bayer-Garner
    Marshfield Clinic, Marshfield, WI 54449, USA
    J Cutan Pathol 31:625-9. 2004
    ..It is essential that the latter two be ruled out before accepting the diagnosis of an extrathyroidal carcinoma with thymus-like differentiation...
  6. ncbi The expression of syndecan-1 is preferentially reduced compared with that of E-cadherin in acantholytic squamous cell carcinoma
    I B Bayer-Garner
    Department of Pathology, University of Arkansas for Medical Sciences, Little Rock 72205, USA
    J Cutan Pathol 28:83-9. 2001
    ....
  7. ncbi Plasma cells in chronic endometritis are easily identified when stained with syndecan-1
    I B Bayer-Garner
    Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, USA
    Mod Pathol 14:877-9. 2001
    ....
  8. ncbi Expression of syndecan-1 is a sensitive marker for cutaneous plasmacytoma
    Ilene B Bayer-Garner
    Department of Pathology, University of Arkansas for Medical Sciences, 4301 West Markham Street, Little Rock, AR 72205, USA
    J Cutan Pathol 30:18-22. 2003
    ..CONCLUSION: Syndecan-1 was found to be a sensitive marker for plasmacytomas, independent of cytologic differentiation...
  9. ncbi Syndecan-1 (CD138) immunoreactivity in bone marrow biopsies of multiple myeloma: shed syndecan-1 accumulates in fibrotic regions
    I B Bayer-Garner
    Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, USA
    Mod Pathol 14:1052-8. 2001
    ..Because syndecan-1 can act to regulate the activity of heparan-binding growth factors, these reservoirs of syndecan-1 may play a critical role in promoting myeloma pathogenesis, or in regeneration of the tumor after chemotherapy...
  10. ncbi Detection of clonality with kappa and lambda immunohistochemical analysis in cutaneous plasmacytomas
    Ilene B Bayer-Garner
    Department of Pathology, Marshfield Clinic, Marshfield, Wis 54449, USA
    Arch Pathol Lab Med 128:645-8. 2004
    ..However, since poorly differentiated lesions may resemble other neoplasms, such as carcinoma, melanoma, and lymphoma, the diagnosis of cutaneous plasmacytoma may be difficult...
  11. ncbi Mycobacteria other than Mycobacterium tuberculosis are not present in erythema induratum/nodular vasculitis: a case series and literature review of the clinical and histologic findings
    Ilene B Bayer-Garner
    Marshfield Clinic, Marshfield, WI 54449, USA
    J Cutan Pathol 32:220-6. 2005
    ..The cases analysed may not have had an infectious aetiology. However, in EI/NV, performance of PCR for MOTT as well as M. tuberculosis complex may still be beneficial, particularly in cases from immunocompromised hosts...
  12. ncbi Leukocytoclastic (small vessel) vasculitis in multiple myeloma
    I B Bayer-Garner
    Department of Pathology, Marshfield Clinic, Marshfield, WI, USA
    Clin Exp Dermatol 28:521-4. 2003
    ..Overexpression of interleukin 6, which is necessary for myeloma cell growth and survival, may contribute to the pathogenesis of LCV in the setting of MM...
  13. ncbi Sweet syndrome in multiple myeloma: a series of six cases
    I B Bayer-Garner
    Department of Pathology, Baylor Medical College, Houston, TX, USA
    J Cutan Pathol 30:261-4. 2003
    ..The immunoglobulin secretory status parallels that seen in MM with cutaneous involvement, but IgG secretors may be at an increased risk of developing SS compared with their counterparts who secrete other immunoglobulins...
  14. ncbi CD117, but not lysozyme, is positive in cutaneous plasmacytoma
    Ilene B Bayer-Garner
    Department of Pathology, Marshfield Clinic, Marshfield, Wis, USA
    Arch Pathol Lab Med 127:1596-8. 2003
    ..The possibility of c-kit inhibitors being used in the treatment of other hematopoietic malignancies allows speculation regarding implications for the treatment of multiple myeloma...
  15. ncbi The spectrum of cutaneous disease in multiple myeloma
    Ilene B Bayer-Garner
    Department of Pathology, University of Arkansas for Medical Sciences, Little Rock 72205, USA
    J Am Acad Dermatol 48:497-507. 2003
    ....
  16. ncbi Syndecan-1 is strongly expressed in the anagen hair follicle outer root sheath and in the dermal papilla but expression diminishes with involution of the hair follicle
    Ilene B Bayer-Garner
    Department of Pathology, University of Arkansas for Medical Sciences, Little Rock 72205, USA
    Am J Dermatopathol 24:484-9. 2002
    ..Syndecan-1 was also present in the dermal papilla of the anagen hair follicle, where it may promote growth factor-mediated cell signaling that induces and maintains growth of the hair shaft and the inner root sheath...
  17. ncbi Epithelial sheath neuroma: a case report and discussion of the literature
    Tai-Yuan David Lin
    Department of Pathology, University of Alabama at Birmingham, Birmingham, AL 35213, USA
    Am J Dermatopathol 28:216-9. 2006
    ..It is important for the pathologist and dermatologist to be cognizant of this lesion to prevent misdiagnosis of perineural invasion...
  18. ncbi Expression of CD138 (Syndecan-1) in renal cell carcinoma is reduced with increasing nuclear grade
    Neriman Gokden
    Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, AR, USA
    Appl Immunohistochem Mol Morphol 14:173-7. 2006
    ..2) or local stage (P=0.7). Metastatic foci showed a mild to moderate decrease in intensity compared with primary tumor. Decreased expression of CD138 may have a role in more aggressive behavior of clear-cell RCC...
  19. ncbi Keratosis lichenoides chronica
    Tara D Miller
    Department of Dermatology, Baylor College of Medicine, Houston, TX 77030, USA
    Int J Dermatol 43:947-50. 2004